Pfizer three-dose COVID vaccine 80% effective against symptomatic omicron infection for youngest children Monday, May 23 by ABC News(NEW YORK) -- In long-awaited data, Pfizer said its 3-dose vaccine was 80% effective against symptomatic omicron COVID-19 infection among children 6 months to under 5 years old.The company cautioned that estimate was preliminary and could be adjusted as more data is collected. The... Read More.
COVID-19 live updates: Moderna vaccine 93% effective against symptomatic disease after 6 months Thursday, August 5 by ABC News(NEW YORK) -- The United States is facing a COVID-19 surge this summer as the more contagious delta variant spreads.More than 614,000 Americans have died from COVID-19 and over 4.2 million people have died worldwide, according to real-time data compiled by the Center for... Read More.
Novavax announces its COVID-19 vaccine is over 90% effective against symptomatic disease Monday, June 14 by ABC News(LONDON) -- American biotechnology company Novavax announced Monday that its experimental COVID-19 vaccine was more than 90% effective against symptomatic disease in late-stage clinical trials.Results from the Phase 3 trial, which enrolled nearly 30,000 participants across 119 sites in the United States and Mexico,... Read More.
Real world study shows mRNA vaccines protect against symptomatic and asymptomatic infection: CDC Monday, March 29 by ABC NewsBY: IVAN PERIERA, ABC NEWS (NEW YORK) — The U.S. Centers for Disease Control and Prevention released new data Monday bolstering previous studies that showed mRNA vaccines are effective at preventing asymptomatic COVID-19 cases. The agency studied 3,950 people who received the Pfizer and... Read More.
